BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17134566)

  • 1. [Clinicopathologic study of breast cancer with features of endocrine ductal carcinoma-in-situ].
    Yang WT; Xu YX; Zhang TQ
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):594-7. PubMed ID: 17134566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
    Tsang WY; Chan JK
    Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
    Ding HY; Gao LX
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic study of solid papillary carcinoma of breast].
    Wei B; Bu H; Chen HJ; Zhang HY; Li XJ
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):589-93. PubMed ID: 17134565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
    Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
    Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
    Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
    Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast--comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases.
    Kawasaki T; Nakamura S; Sakamoto G; Murata S; Tsunoda-Shimizu H; Suzuki K; Takahashi O; Nakazawa T; Kondo T; Katoh R
    Histopathology; 2008 Sep; 53(3):288-98. PubMed ID: 18657193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of CD56 and CD57 immunostainings for discrimination between endocrine ductal carcinoma in situ and intraductal papilloma.
    Tajima S; Maeda I; Kanemaki Y; Nakajima Y; Tatsunami S; Fukuda M; Takagi M
    Pathol Int; 2010 Jun; 60(6):459-65. PubMed ID: 20518901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.
    Kelten Talu C; Savli TC; Huq GE; Leblebici C
    Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-needle aspiration cytology of breast carcinoma with endocrine differentiation.
    Tse GM; Ma TK
    Cancer; 2000 Oct; 90(5):286-91. PubMed ID: 11038425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary endocrine ductal carcinoma in situ: a case report.
    Danikas D; Matthews WE; Averbach DJ
    Am Surg; 2000 Dec; 66(12):1163-4. PubMed ID: 11149590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous bilateral neuroendocrine ductal carcinoma in situ.
    Honami H; Sotome K; Sakamoto G; Iri H; Tanaka Y; Fukamachi S; Morozumi K
    Breast Cancer; 2014 Jul; 21(4):508-13. PubMed ID: 21735237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
    Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
    Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT; Koerner FC; Lerwill MF
    Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases.
    Kelten Talu C; Leblebici C; Kilicaslan Ozturk T; Hacihasanoglu E; Baykal Koca S; Gucin Z
    Ann Diagn Pathol; 2018 Jun; 34():122-130. PubMed ID: 29661717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin-negative primary small cell carcinoma of the breast. Report of a case and review of the literature.
    Bergman S; Hoda SA; Geisinger KR; Creager AJ; Trupiano JK
    Am J Clin Pathol; 2004 Jan; 121(1):117-21. PubMed ID: 14750249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].
    Yang G; Guo L; Jin H; Li J; Ding H
    Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Invasive carcinoma arising in breast microglandular adenosis: a clinicopathologic study of three cases and review of the literature].
    Shui RH; Cheng YF; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):471-4. PubMed ID: 22088374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ (DCIS): a revised concept.
    Gump FE; Jicha DL; Ozello L
    Surgery; 1987 Nov; 102(5):790-5. PubMed ID: 2823405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.